ArticleMedChemComm2017

Development of new scaffolds as reversible tissue transglutaminase inhibitors, with improved potency or resistance to glutathione addition.

Kim Y P Apperley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.